Scientist II (Drug Product Manufacturing)

Assess and compare emerging formulation and process technologies including Glatt fluid-bed granulation, drying, and Wurster coating platforms to determine how these capabilities can address current client challenges and support future CDMO project opportunities. Provide scientific input to link laboratory and pilot-scale Glatt processing data with client needs, market trends, and areas where our capabilities can offer differentiated technical value. Design and conduct feasibility studies and pilot-scale evaluations for client programs involving advanced drug delivery systems, multiparticulates, or continuous processing concepts using Glatt equipment. This includes optimizing atomization conditions, spray rates, inlet temperatures, and product temperatures to meet project-specific CQAs. Work closely with development team to confirm the technical viability of client-requested processes and collaborate with project teams to translate these findings into development plans tailored to client timelines and regulatory expectations. Perform API solubility studies, forced degradation and physical evaluations of finished dosage forms to directly link laboratory and pilot-scale Glatt processing data to client needs and market expectations. Prepare detailed analytical and scientific reports to clearly communicate experimental outcomes, trends, deviations and next steps, and present both technical and non-technical audiences Glatt’s processing results, scale-up implications, and development recommendations are understood by internal teams, Business Development, and client technical group.